
First device to monitor transplanted organs detects early signs of rejection
Wireless technology senses warning signs up to three weeks earlier than current methods
Wireless technology senses warning signs up to three weeks earlier than current methods
Moximed announced today that doctors completed the first commercial cases for its Misha knee system, an implantable shock absorber (ISA).
The findings point to faster way to detect bacteria in food, water, and clinical samples.
Mountain View, California-based Levita designed its MARS minimally invasive surgical platform for the high-volume abdominal surgery market. It combines magnets and machines to reduce the number of incisions, enabling complete control during laparoscopic procedures.
How mutation in brain cell leads to ALS and offers path for drugs
The Portrait Mobile device is one of GE HealthCare’s “first major introductions in monitoring in recent years,” according to the company.
MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.
A tiny robot which can travel deep into the lungs to detect and treat the first signs of cancer has been developed by researchers at the University of Leeds.